![]() ![]() Direct observations: clinical cases, poisoning incidents and other.Exposure related observations in humans.Endocrine disrupter mammalian screening – in vivo (level 3).Toxicity to reproduction: other studies.Developmental toxicity / teratogenicity.Toxicokinetics, metabolism and distribution.Nanomaterial radical formation potential.Nanomaterial crystallite and grain size.Nanomaterial agglomeration / aggregation.Additional physico-chemical properties of nanomaterials.Additional physico-chemical information.Storage stability and reactivity towards container material.Stability in organic solvents and identity of relevant degradation products.Solubility in organic solvents / fat solubility. ![]() Particle size distribution (Granulometry).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |